Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for renal diseases

Y H Lien1, L W Lai

  • 1Department of Medicine, University of Arizona Health Sciences Center, Tucson, USA. lien@u.arizona.edu

Kidney International. Supplement
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From childhood onset lymphedema to fatal fetal hydrops: Possible modifying genes for a FOXC2 mutation.

Lymphology·2018
Same author

Renal gene therapy.

Methods in molecular medicine·2011
Same author

pANCA-positive microscopic polyangiitis in a patient with IgM monoclonal gammopathy.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Influence of oxygen defects on the crystal structure and magnetic properties of the (Tb1-xNax)MnO3-y (0<or=x<or=0.3) system.

Inorganic chemistry·2007
Same author

Chemical size effect on the magnetic and electrical properties in the (Tb(1-)(x)Eu(x))MnO(3) (0 < or = x < or = 1.0) system.

The journal of physical chemistry. B·2007
Same author

Unexpected diagnosis of fabry disease in an 80-year-old man with syncope.

Cardiology·2001

Gene therapy offers potential for treating kidney diseases by transferring genes in vivo. However, challenges like short expression, low efficiency, and immune responses require further research for effective renal gene therapy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy presents a promising strategy for treating diverse inherited and acquired renal diseases.
  • In vivo gene transfer techniques utilizing viral and non-viral vectors have been explored in kidney research.
  • Animal models of renal conditions such as glomerulonephritis and ischemic renal failure have been used to test these gene therapy approaches.

Purpose of the Study:

  • To review the current state of gene therapy for renal diseases.
  • To highlight the critical factors for successful kidney-targeted gene therapy.
  • To identify existing limitations and future research directions in the field.

Main Methods:

  • Review of in vivo gene transfer studies in animal models of renal diseases.

Related Experiment Videos

  • Analysis of viral and non-viral vector systems for kidney gene delivery.
  • Evaluation of therapeutic gene selection and delivery routes for renal applications.

    • Main Results:

    • Gene therapy has shown potential in animal models for various kidney diseases.
    • Vector choice, delivery route, and gene selection are crucial for targeted kidney therapy.
    • Current limitations include short transgene expression, inadequate transfection efficiency, and vector-induced adverse effects like immune reactions and insertional mutagenesis.

    Conclusions:

    • Further research is essential to enhance gene delivery efficiency and duration in the kidney.
    • Minimizing side effects, such as immune responses and insertional mutagenesis, is a key challenge.
    • Development of cell-specific and long-term regulated gene expression systems is critical for advancing renal gene therapy.